Home›Companies›Biotech & Pharma›Rila Therapeutics

Rila Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 7, 2025·Suggest an edit

About Rila Therapeutics

Rila Therapeutics is a private company based in South San Francisco, California, incorporated in 2021 in Delaware. It has reported $6,978,195 raised in one offering on Form D since January 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 20, 2024Jan 7, 2025$6,978,195of $10.7M target3$2.3MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Rila Therapeutics's Form D filed Jan 7, 2025.

RD
Robert Drakas
President and director
MH
Michael Hui
Director
WD
William Dai
Director

Sources

  1. SECRila Therapeutics, Inc. filing history